All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 1980-03-28? to Thu 2025-12-04 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
+44.77%
2025-12-04 |
105.56 TRR
2025-12-04 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Thu 2025-12-04 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+10,456.40%
+10.74%/yr |
+7.73%/yr
(R2=0.689) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Thu 2025-12-04 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1980-03-28 |
$1,055,640.08
2025-12-04 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2025 (YTD) | +44.77% |
| 2024 | −7.78% |
| 2023 | +6.16% |
| 2022 | −21.83% |
| 2021 | +18.42% |
| 2020 | −18.82% |
| 2019 | +26.35% |
| 2018 | +11.66% |
| 2017 | −5.00% |
| 2016 | +0.03% |
| 2015 | −0.99% |
| 2014 | −16.30% |
| 2013 | +27.02% |
| 2012 | −1.07% |
| 2011 | +19.07% |
| 2010 | −3.59% |
| 2009 | +16.17% |
| 2008 | −22.33% |
| 2007 | −4.66% |
| 2006 | +5.28% |
| 2005 | +6.22% |
| 2004 | +2.28% |
| 2003 | +26.35% |
| 2002 | −23.40% |
| 2001 | −11.02% |
| 2000 | +0.75% |
| 1999 | −20.08% |
| 1998 | +45.87% |
| 1997 | +53.24% |
| 1996 | +14.14% |
| 1995 | +41.72% |
| 1994 | +0.35% |
| 1993 | −12.82% |
| 1992 | −25.07% |
| 1991 | +93.00% |
| 1990 | +22.93% |
| 1989 | +32.56% |
| 1988 | +2.47% |
| 1987 | +15.83% |
| 1986 | +42.44% |
| 1985 | +80.37% |
| 1984 | +26.22% |
| 1983 | −5.47% |
| 1982 | +149.15% |
| 1981 | +15.72% |
| 1980 | +15.87% |
| Fri 1980-03-28? to Thu 2025-12-04 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −99.99% |
−100.00%
1985-09-30 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||